| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/31/2006 | WO2006091428A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | WO2006091246A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/31/2006 | WO2006090997A1 Isoxazoline derivative and novel process for its preparation |
| 08/31/2006 | WO2006090915A1 Pyridyl acetic acid compounds |
| 08/31/2006 | WO2006090853A1 Nitrogenous heterocyclic compound and medicinal use thereof |
| 08/31/2006 | WO2006090817A1 Indole compound and use thereof |
| 08/31/2006 | WO2006090743A1 1-(2h)-isoquinolone derivative |
| 08/31/2006 | WO2006090224A1 Benzisoxazole derivatives |
| 08/31/2006 | WO2006090143A1 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 08/31/2006 | WO2006089872A1 Glucopyranosyl-substituted ( (hetero)arylethynyl-benzyd-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 08/31/2006 | WO2006089700A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | WO2006074940A3 Macrocyclic compounds and compositions useful as bace inhibitors |
| 08/31/2006 | WO2006074388A3 TRICYCLIC δ-OPIOID MODULATORS |
| 08/31/2006 | WO2006072393A3 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 08/31/2006 | WO2006066896A3 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 08/31/2006 | WO2006062984A3 Inhibitors of protein kinases |
| 08/31/2006 | WO2006035068A3 Hiv inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 08/31/2006 | WO2006010077A3 Prodrugs of lonidamine and lonidamine analogs |
| 08/31/2006 | WO2005035507A3 4-aminopyrimidine derivatives for treatment of hyperproliferative disorders |
| 08/31/2006 | US20060194969 4-Substituted benzimidazoles and their uses as inhibitors of gastric secretion |
| 08/31/2006 | US20060194966 N'-{2-amino-1-(3,5-difluorobenzyl)-3-[(3-; ethylbenzyl)oxy]propyl}-N,N-dipropylisophthalamide; beta-secretase inhibitors; halts or reduces production of A beta peptide from amyloid precursor proteins and reduces or eliminates the formation of beta-amyloid deposits in the brain |
| 08/31/2006 | US20060194864 Indole derivatives |
| 08/31/2006 | US20060194863 e.g. [(4-Morpholinophenylamino)-methylene]-1,3-dihydro-indol-2-one;tyrosine kinase signal transduction modulators; antiproliferative agents; vision defects, atherosclerosis, restenosis, metabolic disorders, autoimmune diseases |
| 08/31/2006 | US20060194859 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 08/31/2006 | US20060194851 Benzofuran compound and medicinal composition containing the same |
| 08/31/2006 | US20060194848 Substituted amine derivatives and methods of use |
| 08/31/2006 | US20060194843 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide; anticancer agents; carcinoma of the colon; antifungal agents; antitumor agents; infections; 4-(2,6-difluoro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methyl-piperidin-4-yl)-amide |
| 08/31/2006 | US20060194842 Oxyindole derivatives |
| 08/31/2006 | US20060194830 Cyclizing 2,6-diaminopyridine in sulfuric acid with malic acid to form 2-amino-7-hydroxy-1,8-naphthyridine; phthalimidating the naphthyridine and replacing the OH with Cl; reducing the product to form the hydroxyindolinone derivative and etherifying with 5-methyl-2-oxo-hexyltriphenylphosphonium halide |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194817 N-{(1S,2R)-1-(3,5-difluorobonzyl)-2-hydroxy-3-[(3-iodobonzyl)amino]propyl}-2-{4-[(methylsulfonyl)amino]phenyl}acetamide; inhibitors of the beta- secretase enzyme useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mamma |
| 08/31/2006 | US20060194804 Hiv replication inhibiting pyrimidines and triazines |
| 08/31/2006 | US20060194803 anti-dementia agent which uses a BEC 1 potassium channel inhibitor as the active ingredient; to improve learning disorder |
| 08/31/2006 | US20060194801 inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist; N-(2,3-Dihydro-benzo[1,4]dioxin-6-yl)-4-((E)-3,3-dimethyl-but-1-enyl)-benzamide; 6-(3,3-Dimethyl-but-1-ynyl)-N-guinolin-3-yl-nicotinamide |
| 08/31/2006 | US20060194799 Novel pyrimidinedione derivatives |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194797 Condensed ring compound and use thereof |
| 08/31/2006 | US20060194794 oxadiazoles such as 2-({[5-(3,4,5,6-Tetrahydro-2H-[1,2']bipyridinyl-4-yl)-[1,3,4]oxadiazol-2-ylmethyl]-amino}-methyl)-phenylamine exhibiting vasopressin antagonistic activity and can be used in the treatment of dysmenorrhea |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060194787 substituted 1,1,4-1l6-trioxo[1,2]thiazepan-4-ylamide-derived protease inhibitors which inhibit the likes of cathepsin K; treating osteoporosis, osteo- and rheumatoid arthritis and periodontal disease; inhibiting excessive cartilage or matrix degradation |
| 08/31/2006 | US20060194783 Cgrp receptor antagonists |
| 08/31/2006 | CA2599348A1 Indole compound and use thereof |
| 08/31/2006 | CA2598943A1 4-0x0quinaz0lin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 08/31/2006 | CA2598934A1 Pyridyl acetic acid compounds |
| 08/31/2006 | CA2598853A1 Pyrrolidine and piperidine acetylene derivatives for use as mglur5 antagonists |
| 08/31/2006 | CA2598418A1 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity |
| 08/31/2006 | CA2598330A1 1-(2h)-isoquinolone derivative |
| 08/31/2006 | CA2598133A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 08/31/2006 | CA2595257A1 Glucopyranosyl-substituted ((hetero)arylethynyl-benzyl)-benzene derivatives and use thereof as sodium-dependent glucose cotransporter 2 (sglt2) inhibitors |
| 08/31/2006 | CA2586080A1 Novel compounds for treatment of cancer and disorders associated with angiogenesis function |
| 08/30/2006 | EP1695968A1 The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
| 08/30/2006 | EP1695967A1 Processes for production of pyrimidine derivatives and intermediates |
| 08/30/2006 | EP1695962A1 Cyclic amine derivative having heteroaryl ring |
| 08/30/2006 | EP1695961A1 Urea derivative, process for producing the same, and use |
| 08/30/2006 | EP1695705A1 Compounds effecting glucokinase |
| 08/30/2006 | EP1694799A2 Process for upgrading naphtha |
| 08/30/2006 | EP1694671A2 Quinoxalines useful as inhibitors of protein kinases |
| 08/30/2006 | EP1694655A2 Phosphodiesterase inhibitors |
| 08/30/2006 | EP1694638A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694410A2 Cyclopropane compounds and pharmaceutical use thereof |
| 08/30/2006 | EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/30/2006 | EP1490056B1 N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetamide and corresponding piperidine derivatives as factor xa inhibitors for the treatment of thrombo-embolic diseases |
| 08/30/2006 | EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 08/30/2006 | EP1335722B1 Indolyl-sulfonyl- compounds useful in the treatment of cns disorders |
| 08/30/2006 | EP1318811B1 Cyclopentyl modulators of chemokine receptor activity |
| 08/30/2006 | EP1071681B1 Nitroxyl derivatives with glycidyl or alkylcarbonyl groups as initiators for radical polymerisation |
| 08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
| 08/30/2006 | CN1826328A Substituted pyridin-2-ylamine analogues |
| 08/30/2006 | CN1826324A Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| 08/30/2006 | CN1826323A 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1826317A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 08/30/2006 | CN1826116A Piperidine derivatives as melanocortin-4 receptor agonists |
| 08/30/2006 | CN1824662A Substituted pyridine herbicides |
| 08/30/2006 | CN1272324C Novel herbicides |
| 08/29/2006 | US7098343 Polycyclic compounds containing a central trivalent atom to which is attached either direct or indirectly via a linker a two or three ring system and a ring system contining sulphamate group as substituent; steroid sulfatase inhibitor |
| 08/29/2006 | US7098340 Quinoline/chromene derivatives as androgen antagonist |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098241 Thiophene hydroxamic acid derivatives |
| 08/29/2006 | US7098240 Compounds |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098238 2-pyrrolidone derivatives that are photolabile degradation products of bilirubin or biliverdin; used to detect vasospasm or vasoconstriction |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/29/2006 | US7098228 Indolyl derivatives |
| 08/29/2006 | US7098222 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 08/29/2006 | US7098219 Inhibitors of cellular efflux pumps of microbes |
| 08/29/2006 | US7098210 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 08/29/2006 | US7097706 non-calcined clay composite includes clay, lime, blast furnace slag, alkaline chemical, and water in specified amounts, and has high compression strength due to an ionic coagulation reaction, a pozzolan reaction, and a latent hydraulic reaction |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2149637C Method for the preparation of 1,3-oxazolidin-5-carboxylic acid |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006089177A2 Isoxazole combretastin derivatives for the treatment of disorders |
| 08/24/2006 | WO2006089100A1 Benzoxazole carboxamides for treating cinv and ibs-d |
| 08/24/2006 | WO2006089060A1 Fungicidal pyrazine derivatives |
| 08/24/2006 | WO2006088921A2 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088919A2 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088840A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |